• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 17
  • 7
  • 5
  • 5
  • 3
  • 2
  • 2

PRICE

2
2
2
41

PUBLISHED

0
3
28
41

PRODUCT TYPE

39
2

Search "Cytokinetics Inc.-Therapeutic Competitors" returned 41 results.

PRODUCT TITLE
Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review

Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review Summary Cytokinetics, Inc (Cytokinetics) is a clinical stage biopharmaceutical company involved in the discovery and development...

September 2011
FROM

Cytokinetics, Inc. (CYTK) - Financial and Strategic SWOT Analysis Review

Cytokinetics, Inc. (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by...

April 2015
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM

Myasthenia Gravis - Pipeline Review, H1 2014

Myasthenia Gravis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This...

June 2014
FROM

Myasthenia Gravis - Pipeline Review, H2 2014

Myasthenia Gravis - Pipeline Review, H2 2014 Summary This, ‘Myasthenia Gravis - Pipeline Review, H2 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

December 2014
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM

Sarcopenia - Pipeline Review, H1 2014

Sarcopenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2014’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides...

April 2014
FROM

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

January 2015
FROM

Cachexia - Pipeline Review, H1 2014

Cachexia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cachexia - Pipeline Review, H1 2014’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive...

March 2014
FROM

Intermittent Claudication - Pipeline Review, H1 2014

Intermittent Claudication - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Intermittent Claudication - Pipeline Review, H1 2014’, provides an overview of the Intermittent Claudication’s...

June 2014
FROM

Cachexia - Pipeline Review, H2 2014

Cachexia - Pipeline Review, H2 2014 Summary This, ‘Cachexia - Pipeline Review, H2 2014’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary This, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic...

January 2015
FROM

Pulmonary Hypertension - Pipeline Review, H1 2015

Pulmonary Hypertension - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Hypertension’s therapeutic pipeline. This...

January 2015
FROM

Sarcopenia - Pipeline Review, H2 2014

Sarcopenia - Pipeline Review, H2 2014 Summary This, ‘Sarcopenia - Pipeline Review, H2 2014’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Intermittent Claudication - Pipeline Review, H2 2014

Intermittent Claudication - Pipeline Review, H2 2014 Summary This, ‘Intermittent Claudication - Pipeline Review, H2 2014’, provides an overview of the Intermittent Claudication’s therapeutic pipeline. This...

December 2014
FROM

Intermittent Claudication - Pipeline Review, H1 2015

Intermittent Claudication - Pipeline Review, H1 2015 Summary This, ‘Intermittent Claudication - Pipeline Review, H1 2015’, provides an overview of the Intermittent Claudication’s therapeutic pipeline. This...

January 2015
FROM

Pulmonary Arterial Hypertension - Pipeline Review, H1 2015

Pulmonary Arterial Hypertension - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Arterial Hypertension’s...

March 2015
FROM

Sarcopenia - Pipeline Review, H1 2015

Sarcopenia - Pipeline Review, H1 2015 Summary This, ‘Sarcopenia - Pipeline Review, H1 2015’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

March 2015
FROM

Pulmonary Arterial Hypertension - Pipeline Review, H2 2014

Pulmonary Arterial Hypertension - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Arterial Hypertension - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Arterial Hypertension’s...

October 2014
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group